Coherus Oncology (CHRS) Asset Utilization Ratio (2016 - 2025)
Coherus Oncology (CHRS) has disclosed Asset Utilization Ratio for 12 consecutive years, with 0.11 as the latest value for Q4 2025.
- Quarterly Asset Utilization Ratio rose 96.66% to 0.11 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.11 through Dec 2025, up 96.66% year-over-year, with the annual reading at 0.12 for FY2025, 143.74% up from the prior year.
- Asset Utilization Ratio hit 0.11 in Q4 2025 for Coherus Oncology, up from 0.08 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.58 in Q1 2021 to a low of 0.06 in Q4 2024.
- Historically, Asset Utilization Ratio has averaged 0.34 across 5 years, with a median of 0.41 in 2022.
- Biggest five-year swings in Asset Utilization Ratio: tumbled 86.95% in 2024 and later soared 96.66% in 2025.
- Year by year, Asset Utilization Ratio stood at 0.46 in 2021, then dropped by 10.99% to 0.41 in 2022, then rose by 3.65% to 0.42 in 2023, then crashed by 86.95% to 0.06 in 2024, then surged by 96.66% to 0.11 in 2025.
- Business Quant data shows Asset Utilization Ratio for CHRS at 0.11 in Q4 2025, 0.08 in Q3 2025, and 0.08 in Q2 2025.